{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:18:13Z","timestamp":1790421493841,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.neuropharm.2012.12.003","type":"journal-article","created":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T11:32:53Z","timestamp":1357126373000},"page":"161-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Mechanism based neurotoxicity of mGlu5 positive allosteric modulators \u2013 Development challenges for a promising novel antipsychotic target"],"prefix":"10.1016","volume":"82","author":[{"given":"Sophie","family":"Parmentier-Batteur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Hutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Uslaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta A.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Magliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Forest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Stump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Tynebor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville J.","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Huszar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lambeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Faur\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emannuel","family":"Le Poul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Rosahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hargreaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.12.003_bib56","first-page":"981","article-title":"Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors","volume":"44","author":"Aronica","year":"1993","journal-title":"Mol. Pharmacol"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0306-4522(96)00435-6","article-title":"Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam","volume":"77","author":"Bagley","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuroscience.2006.06.043","article-title":"Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory","volume":"142","author":"Balschun","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib3","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1007\/s00018-008-8263-3","article-title":"Mechanisms of synaptic depression triggered by metabotropic glutamate receptors","volume":"65","author":"Bellone","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-4547(19980201)51:3<339::AID-JNR7>3.0.CO;2-H","article-title":"Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine","volume":"51","author":"Camon","year":"1998","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-008-1103-1","article-title":"Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice","volume":"198","author":"Chan","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib50","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1124\/mol.106.032425","article-title":"Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses","volume":"71","author":"Chen","year":"2007","journal-title":"Mol. Pharmacol"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrd746","article-title":"Allosteric binding sites on cell-surface receptors: novel targets for drug discovery","volume":"1","author":"Christopoulos","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FBP.0b013e3282feb0ac","article-title":"Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm","volume":"19","author":"Darrah","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","article-title":"Correction of fragile X syndrome in mice","volume":"56","author":"D\u00f6len","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2004.06.060","article-title":"The metabotropic glutamate receptor 5 is necessary for late-phase long-term potentiation in the hippocampal CA1 region","volume":"1022","author":"Francesconi","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0896-6273(00)80442-0","article-title":"Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5","volume":"20","author":"Gereau","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1124\/pr.109.001735","article-title":"Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms","volume":"61","author":"Gladding","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1192\/bjp.169.5.610","article-title":"Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia","volume":"169","author":"Heresco-Levy","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib54","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1176\/appi.ajp.159.3.480","article-title":"Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia","volume":"159","author":"Heresco-Levy","year":"2002","journal-title":"American J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archpsyc.56.1.29","article-title":"Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia","volume":"56","author":"Heresco-Levy","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/0264-6021:3590465","article-title":"Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors","volume":"359","author":"Hermans","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00001756-199211000-00017","article-title":"3,5-Dihydroxyphenyl-glycine: a potent agonist of metabotropic glutamate receptors","volume":"3","author":"Ito","year":"1992","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib52","first-page":"12","article-title":"Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia","volume":"9","author":"Javitt","year":"1987","journal-title":"Hillside J. Clinic. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1101\/lm.5.4.331","article-title":"Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5","volume":"5","author":"Jia","year":"1998","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.103.048702","article-title":"Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents","volume":"306","author":"Kinney","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/jpet.104.079244","article-title":"A\u00a0novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in\u00a0vivo activity and antipsychotic-like effects in rat behavioral models","volume":"313","author":"Kinney","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib19","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1021\/jm049400d","article-title":"Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in\u00a0vivo","volume":"47","author":"Lindsley","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.108.136580","article-title":"ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piper idin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities","volume":"327","author":"Liu","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.1995.65010268.x","article-title":"Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats","volume":"65","author":"Lowy","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib22","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1523\/JNEUROSCI.17-13-05196.1997","article-title":"Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP","volume":"17","author":"Lu","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib23","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1073\/pnas.96.15.8739","article-title":"Novelty acquisition is associated with induction of hippocampal long-term depression","volume":"96","author":"Manahan-Vaughan","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib49","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/cercor\/bhi047","article-title":"The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cereb","volume":"15","author":"Manahan-Vaughan","year":"2005","journal-title":"Cortex"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib24","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1523\/JNEUROSCI.21-16-05925.2001","article-title":"Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function","volume":"21","author":"Mannaioni","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2012.03.009","article-title":"Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice","volume":"74","author":"Michalon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuropharm.2008.06.056","article-title":"Presynaptic mGlu1 and mGlu5 autoreceptors facilitate glutamate exocytosis from mouse cortical nerve endings","volume":"55","author":"Musante","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.103.061747","article-title":"A\u00a0novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain","volume":"309","author":"O'Brien","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.nucmedbio.2007.07.009","article-title":"Species differences in mGluR5 binding sites in mammalian central nervous system determined using in\u00a0vitro binding with [18F]F-PEB","volume":"34","author":"Patel","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib51","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1471-4159.2002.01113.x","article-title":"Differential regulation of metabotropic glutamate receptor 5-mediated phosphoinositide hydrolysis and extracellular signal-regulated kinase responses by protein kinase C in cultured astrocytes","volume":"83","author":"Peavy","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","article-title":"The metabotropic glutamate receptors: structure and functions","volume":"34","author":"Pin","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib32","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1111\/j.1460-9568.2007.05560.x","article-title":"Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment","volume":"25","author":"Reznikov","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","article-title":"Glutamate receptor function in learning and memory","volume":"140","author":"Riedel","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9","article-title":"Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: protein, mRNA splice variants, and regional distribution","volume":"367","author":"Romano","year":"1996","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3940(92)90862-2","article-title":"Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage","volume":"139","author":"Sacaan","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pbb.2009.12.002","article-title":"Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia","volume":"95","author":"Schlumberger","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0079-6123(06)57003-7","article-title":"Signal transduction mechanisms in memory disorders","volume":"157","author":"Shalin","year":"2006","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1358\/dnp.2005.18.6.927927","article-title":"The role of metabotropic glutamate receptor 5 in learning and memory processes","volume":"18","author":"Simonyi","year":"2005","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2011.02.003","article-title":"Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator","volume":"659","author":"Spear","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib43","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0028-3908(98)00138-5","article-title":"Roles of metabotropic glutamate receptor subtypes in modulation of pentylenetetrazole-induced seizure activity in mice","volume":"37","author":"Thomsen","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib44","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0028-3908(95)00083-I","article-title":"Induction or protection of limbic seizures in mice by mGluR subtype selective agonists","volume":"34","author":"Tizzano","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib45","first-page":"17","article-title":"Polymorphisms in glycine transporter with schizophrenia","volume":"8","author":"Tsai","year":"2006","journal-title":"Neuropsychopharmacol. Hung."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib55","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(98)00279-0","article-title":"D-serine added to antipsychotics for the treatment of schizophrenia","volume":"44","author":"Tsai","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuropharm.2009.07.022","article-title":"Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus","volume":"57","author":"Uslaner","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.12.003_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0031-9384(00)00260-2","article-title":"The relationship between audiogenic seizure (AGS) susceptibility and forebrain tone-responsiveness in genetically AGS-prone Wistar rats","volume":"70","author":"Valjakka","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2012.12.003_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pbb.2010.01.010","article-title":"MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?","volume":"95","author":"Vardigan","year":"2010","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812005965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812005965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T20:54:29Z","timestamp":1644008069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812005965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":54,"alternative-id":["S0028390812005965"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.12.003","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism based neurotoxicity of mGlu5 positive allosteric modulators \u2013 Development challenges for a promising novel antipsychotic target","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}